Jun 2, 2026 04:05PM
Jun 2, 2026 04:05PM
May 14, 2026 04:09PM
May 14, 2026 04:07PM
Apr 30, 2026 04:15PM
Apr 30, 2026 04:15PM
Apr 30, 2026 04:07PM Cue Biopharma appoints Shao-Lee Lin as CEO and president
Apr 30, 2026 04:05PM
Apr 22, 2026 08:37AM
Apr 22, 2026 08:37AM
Apr 15, 2026 08:01AM
Apr 15, 2026 08:00AM
Apr 8, 2026 08:00AM
Apr 8, 2026 08:00AM Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement
Mar 27, 2026 04:05PM
Mar 27, 2026 04:05PM
Mar 26, 2026 08:00AM
Mar 16, 2026 04:05PM
Mar 9, 2026 08:00AM
Feb 17, 2026 08:00AM
Feb 12, 2026 08:02AM Cue Biopharma names Lucinda Warren as chief financial and business officer
Feb 12, 2026 08:00AM
Nov 12, 2025 04:05PM
Nov 6, 2025 08:02AM
Nov 6, 2025 08:00AM
Sep 29, 2025 09:00AM
Sep 29, 2025 09:00AM
Aug 13, 2025 08:00AM Cue Biopharma Announces Initiation of Investigator Sponsored Trial of CUE-102 in Recurrent Glioblastoma Multiforme
Aug 12, 2025 04:05PM
Jul 16, 2025 08:00AM
Jul 16, 2025 08:00AM
Jul 1, 2025 04:05PM
Jul 1, 2025 04:05PM
Jun 24, 2025 04:48PM
Jun 24, 2025 04:48PM Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company’s Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease
May 12, 2025 04:05PM
May 8, 2025 08:00AM
Apr 14, 2025 05:00PM
Apr 14, 2025 05:00PM
Mar 31, 2025 04:20PM
Nov 14, 2024 04:05PM
Nov 14, 2024 08:00AM Cue Biopharma Announces Strategic Organizational Transition
Nov 8, 2024 01:31PM
Nov 8, 2024 01:30PM
Sep 9, 2024 08:03AM
Sep 9, 2024 08:00AM
Sep 3, 2024 08:00AM
Aug 19, 2024 04:05PM
Jul 25, 2024 04:05PM Cue Biopharma (CUE) Announces Strategic Prioritization of Autoimmune Programs
Jul 25, 2024 04:05PM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All